Somatus Raises $11 Million in Series B Financing
Innovative Kidney Care Company works with Health Systems and Payers to enable value-based care for CKD and ESRD populations VIENNA, Va., April 11, 2018 -- (Healthcare Sales & Marketing Network) -- Somatus, an innovative care delivery and management com... Devices, Venture Capital Somatus, Chronic Kidney Disease, End Stage Renal Disease, dialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2018 Category: Pharmaceuticals Source Type: news

Macrophage Pharma Appoints Dr Michael Moore as Chairman
WINDSOR, England, April 11, 2018 -- (Healthcare Sales & Marketing Network) -- Macrophage Pharma Limited ('MPL'), a company focused on the discovery and development of next-generation small molecules aiming to modulate immune responses to combat cancer and... Biopharmaceuticals, Personnel Macrophage Pharma, Esterase Motif Technology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2018 Category: Pharmaceuticals Source Type: news

Wound Management Technologies Changes Name to WNDM Medical
New name better reflects breadth of products and long-term vision for growth FORT WORTH, Texas (April 10, 2018) -- (Healthcare Sales & Marketing Network) -- Wound Management Technologies Inc. announced today that it is changing its name to WNDM Medical ... Devices, Surgery, Wound Care WNDM Medical, Wound Management Technologies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2018 Category: Pharmaceuticals Source Type: news

Geistlich Bio-Gide(R) Portfolio Expands
The Collagen Expert, Geistlich Biomaterials Launches Two NEW Resorbable Collagen Membranes to Enhance Clinical Procedures PRINCETON, N.J., April 10, 2018 -- (Healthcare Sales & Marketing Network) -- Geistlich Pharma North America, Inc., introduces Gei... Devices, Dental, Product Launch Geistlich Pharma, Bio-Gide, collagen membrane (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2018 Category: Pharmaceuticals Source Type: news

TCR2 Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer
CAMBRIDGE, Mass., April 10, 2018 -- (Healthcare Sales & Marketing Network) -- TCR2 Therapeutics Inc., an immuno-oncology company pioneering a novel class of T cell receptor (TCR)-based cellular therapies for solid tumors and blood cancers, announced today... Biopharmaceuticals, Oncology, Personnel TCR2 Therapeutics, TRuC , immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2018 Category: Pharmaceuticals Source Type: news

Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma
Once approved, this product could represent a significant milestone for patients with relapsing-remitting multiple sclerosis Mapi Pharma has completed an open-label Phase II clinical trial and is preparing to commence a pivotal Phase III clinical trial ... Biopharmaceuticals, Neurology, Acquisitions Mylan, Mapi Pharma, GA Depot, Glatiramer, multiple sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2018 Category: Pharmaceuticals Source Type: news

Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner
RESEARCH TRIANGLE PARK, N.C., April 10, 2018 -- (Healthcare Sales & Marketing Network) -- Pappas Capital announced today that Thomas P. "Tom" Mathers has joined the firm as a partner. Mathers previously served as CEO of CoLucid Pharmaceuticals (... Biopharmaceuticals, Venture Capital, Personnel Pappas Capital (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 10, 2018 Category: Pharmaceuticals Source Type: news

Cumberland Pharmaceuticals Expands into Oncology Support
FDA-approved Ethyol® and Totect® address harmful effects of cancer treatments to help improve the quality of life for oncology patients NASHVILLE, Tenn., April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Cumberland Pharmaceuticals – an... Biopharmaceuticals, Oncology, Licensing, Distribution Cumberland Pharmaceuticals, Ethyol, Totect (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Fischer Medical Receives U.S. FDA 510(k) Clearance to Market Bloom2 Cardiac Stimulator
DENVER, April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Fischer Medical has announced that the Bloom2 cardiac electrophysiology stimulator device has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The Bloom2 stimulator is a... Devices, Cardiology, FDA Fischer Medical, Bloom2, Cardiac Stimulator, electrophysiology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Intezyne Promotes Adam Carie, PhD to Director, Product Development
TAMPA, Fla., April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has promoted Adam Carie, PhD to Director, Product Development. In his ne... Biopharmaceuticals, Oncology, Personnel Intezyne Technologies, Cancer Resistance Pathway, topoisomerase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer
Leading authority on genomics and diagnostics in medical practice will help Natera's efforts in advancing individualized genomic medicine SAN CARLOS, Calif., April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Natera (NASDAQ: NTRA), a leader in ... Diagnostics, Personnel Natera, cell-free DNA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Omnicell Appoints Scott Seidelmann as Chief Commercial Officer
New Role will Focus on Emerging Digital Health Technologies and Supporting Customer and Market Needs MOUNTAIN VIEW, Calif., April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and s... Devices, Personnel Omnicell, supply management (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
ROCKVILLE, Md., April 9, 2018 -- (Healthcare Sales & Marketing Network) -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair an... Biopharmaceuticals, Ophthalmology, FDA RegeneRx Biopharmaceuticals, ReGenTree, Dry Eye (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Elekta Strengthens Presence in Mexico With Government Tender for Radiation Therapy Technology
Elekta further invests in Mexico with new offices and fortified workforce MEXICO, April 9, 2018 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) announced today that it has won a government tender to supply Instituto Mexicano del Seguro ... Devices, Oncology Elekta, Elekta Synergy, Elekta Infinity, linear accelerator, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2018 Category: Pharmaceuticals Source Type: news

Teligent, Inc. Announces FDA Approval of Ciclopirox Shampoo, 1%
BUENA, N.J., April 06, 2018 -- (Healthcare Sales & Marketing Network) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (... Biopharmaceuticals, Generics, FDA Teligent, Ciclopirox Shampoo, Ciclopirox (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2018 Category: Pharmaceuticals Source Type: news

Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
BRIDGEWATER, N.J., April 6, 2018 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has launched a generic version of Estrace® Cream (estradiol vaginal cream, US... Biopharmaceuticals, Generic, Product Launch Impax Laboratories, Perrigo Company, Estrace Cream, estradiol vaginal cream (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2018 Category: Pharmaceuticals Source Type: news

Former Acelity, JandJ Executive Joins Organogenesis as Vice President of Global Medical and Clinical Affairs
Dr. Shabnam Vaezzadeh Joins Organogenesis Leadership Team in Strategic Medical Direction Role CANTON, Mass., April 5, 2018 -- (Healthcare Sales & Marketing Network) -- Shabnam Vaezzadeh, MD, MPA, formerly of Acelity, KCI, and Johnson & Johnson LifeScan... Regenerative Medicine, Personnel Organogenesis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2018 Category: Pharmaceuticals Source Type: news

AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes with Samsung Bioepis
Agreements Provide Non-Exclusive License to Samsung Bioepis for HUMIRA-Related Intellectual Property in the U.S. Effective June 30, 2023, and in Other Markets on Different Dates Samsung Bioepis Acknowledges Validity of AbbVie's Intellectual Property for... Biopharmaceuticals, Litigation, Licensing AbbVie, Samsung Bioepis, biosimilar, HUMIRA, adalimumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2018 Category: Pharmaceuticals Source Type: news

Eidos Therapeutics completes $64M Series B financing
Funding supports Phase 2 clinical trials of AG10, a potential best-in-class therapy for transthyretin amyloidosis, and ongoing preparation for Phase 3 clinical trials SAN FRANCISCO, April 5, 2018 -- (Healthcare Sales & Marketing Network) -- Eidos Thera... Biopharmaceuticals, Venture Capital Eidos Therapeutics, transthyretin amyloidosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2018 Category: Pharmaceuticals Source Type: news

Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Financing round led by Nextech Invest Proceeds to advance lead oncology programs into the clinic and broaden early-stage pipeline NEW HAVEN, Conn., April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Arvinas LLC, a private biotechnology compa... Biopharmaceuticals, Venture Capital, Personnel Arvinas, Proteolysis Targeting Chimeras (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Abide Therapeutics Appoints Thomas C. Südhof to Board of Directors
SAN DIEGO, April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes with an emphasis on CNS disorder... Biopharmaceuticals, Personnel Abide Therapeutics, serine hydrolase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes
Sigilon's Afibromer technology will be used to encapsulate insulin-producing cells for the potential treatment of type 1 diabetes Sigilon to receive upfront payment of $63 million and undisclosed equity investment INDIANAPOLIS and CAMBRIDGE, Mass., A... Biopharmaceuticals, Endocrinology, Licensing Eli Lilly, Sigilon Therapeutics, encapsulated cell therapies, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018
Booth announces retirement; Director Diane Gulyas also to retire from Board in May 2018 STAINES-UPON-THAMES, United Kingdom, April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceuti... Biopharmaceuticals, Personnel Mallinckrodt (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Both to become independent directors pending May 2018 Annual General Meeting approval STAINES-UPON-THAMES, United Kingdom, April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutica... Biopharmaceuticals, Personnel Mallinckrodt (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Proteostasis Therapeutics Receives FDA Fast Track Designation for Triple Combination Program in Patients with Cystic Fibrosis
CAMBRIDGE, Mass., April 4, 2018 -- (Healthcare Sales & Marketing Network) -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic f... Biopharmaceuticals, FDA Proteostasis Therapeutics, transmembrane conductance regulator, cystic fibrosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 4, 2018 Category: Pharmaceuticals Source Type: news

Improving Cardiology Care: BIOTRONIK US to Distribute Aziyo ECM Envelopes
BioEnvelope Reduces Scarring, Improves Device Stability LAKE OSWEGO, Ore. and SILVER SPRING, Md., April 3, 2018 -- (Healthcare Sales & Marketing Network) -- BIOTRONIK US and Aziyo today announced a strategic agreement allowing BIOTRONIK to distribute A... Devices, Cardiology, Distribution BIOTRONIK, Aziyo Biologics, CanGaroo (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

Oncternal Therapeutics Further Strengthens Leadership with Additions to Board of Directors
William R. LaRue and Charles Theuer, M.D., Ph.D., Bring Broad Experience in Executive Leadership, Corporate Finance and Oncology Drug Development SAN DIEGO, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Oncternal Therapeutics, Inc., a cli... Biopharmaceuticals, Oncology, Personnel Oncternal Therapeutics, cirmtuzumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of RandD and Chief Medical Officer
Dr. Vitolo brings wide range of experience in clinical psychiatry, neurology and rare diseases to lead Relmada development programs NEW YORK, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinica... Biopharmaceuticals, Personnel Relmada Therapeutics, methadone, mepivacaine, dextromethadone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
NEW YORK, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Bridge Medicines, a pioneering drug discovery company focused on advancing promising early technologies from concept to clinic, announced today the appointment of Louis M. Renzetti, Ph.D... Biopharmaceuticals, Personnel Bridge Medicines (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves GORE(R) CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone FLAGSTAFF, Ariz., April 3, 2018 -- (Healthcare Sales & Mar... Devices, Interventional, Cardiology, FDA W. L. Gore, patent foramen ovale, CARDIOFORM, Septal Occluder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes With AI
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims in latest venture round. OXFORD, England, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Brainomix, a medical imaging company using a... Devices, Neurology, Venture Capital Brainomix, Boehringer Ingelheim, stroke, e-ASPECTS (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform
The Series A financing will support further development of the Company's pipeline of transformative dry powder drugs for pulmonary diseases and conditions. AUSTIN, Texas, April 3, 2018 -- (Healthcare Sales & Marketing Network) -- TFF Pharmaceuticals, I... Biopharmaceuticals, Venture Capital TFF Pharmaceuticals, Thin Film Freezing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

Kleo Pharmaceuticals Inc. Appoints Luca Rastelli, PhD as Chief Scientific Officer
NEW HAVEN, Conn., April 3, 2018 -- (Healthcare Sales & Marketing Network) -- Kleo Pharmaceuticals Inc., a biotechnology company pioneering a new class of immunotherapies utilizing small molecules to activate an individual's own immune system to fight agai... Biopharmaceuticals, Personnel Kleo Pharmaceuticals, Antibody Recruiting Molecules, Synthetic Antibody Mimics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2018 Category: Pharmaceuticals Source Type: news

INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors
PHOENIX, April 02, 2018 -- (Healthcare Sales & Marketing Network) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced the appointment... Biopharmaceuticals, Personnel Insys Therapeutics, cannabidiol, Infantile Spasm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2018 Category: Pharmaceuticals Source Type: news

Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Company strengthens management team with biopharmaceutical veteran bringing extensive commercial experience in life-threatening rare diseases Tim Miller, Ph.D. continues as president and assumes chief scientific officer role NEW YORK and CLEVELAND, A... Biopharmaceuticals, Personnel Abeona Therapeutics, gene therapy, epidermolysis bullosa, Sanfilippo syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2018 Category: Pharmaceuticals Source Type: news

Bardy Diagnostics(TM) Names Ken Nelson Chief Commercial Officer
SEATTLE, April 2, 2018 -- (Healthcare Sales & Marketing Network) -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (&qu... Diagnostics, Cardiology, Monitoring, Personnel Bardy Diagnostics, Carnation Ambulatory Monitor, P-wave centric, cardiac monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2018 Category: Pharmaceuticals Source Type: news

Halyard Health, Inc. Appoints Sarker as Senior Vice President, International
ALPHARETTA, Ga., April 2, 2018 -- (Healthcare Sales & Marketing Network) -- Halyard Health, Inc. today announced that Arjun Sarker has been appointed as senior vice president, international. Previously, Sarker served as Halyard's vice president and genera... Devices, Personnel Halyard Health (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2018 Category: Pharmaceuticals Source Type: news

Endo Agrees to Extend Temporary Stay of FDA Litigation
DUBLIN, April 2, 2018 -- (Healthcare Sales & Marketing Network) -- Endo International plc (NASDAQ: ENDP) today announced that it has agreed to extend a temporary stay of its litigation against the U.S. Food and Drug Administration (FDA). The litigation, ... Biopharmaceuticals, FDA, Litigation Endo , Par Sterile Products, compounding, vasopressin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2018 Category: Pharmaceuticals Source Type: news

Compugen Announces Exclusive License Agreement With MedImmune for the Development of Bi-Specific and Multi-Specific Antibody Products
Compugen will receive $10 million upfront, and is eligible for milestone payments and royalties on any products developed under the license HOLON, Israel, April 2, 2018 -- (Healthcare Sales & Marketing Network) -- Compugen Ltd. (NASDAQ: CGEN), a leader... Biopharmaceuticals, Oncology, Licensing Compugen, MedImmune, AstraZeneca, Bi-Specific, Multi-Specific, Antibody (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2018 Category: Pharmaceuticals Source Type: news

Duchesnay USA Announces Launch of Bonjesta(R) (doxylamine succinate - pyridoxine hydrochloride) in the United States
ROSEMONT, PA, April 2, 2018 -- (Healthcare Sales & Marketing Network) - Duchesnay USA, a pharmaceutical company specializing in women's health, announced the launch of Bonjesta® (doxylamine succinate and pyridoxine hydrochloride), multilayer extended-... Biopharmaceuticals, Product Launch Duchesnay, Bonjesta, doxylamine, pyridoxine, morning sickness (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2018 Category: Pharmaceuticals Source Type: news

Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
DANVERS, Mass., March 30, 2018 -- (Healthcare Sales & Marketing Network) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Todd A. Trapp will be appointed as Vice President and Chief Financi... Devices, Cardiology, Personnel Abiomed, IMPELLA, heart pump (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 30, 2018 Category: Pharmaceuticals Source Type: news

K2M Names Lane Major Chief Operating Officer
Strategic leadership appointment to bolster Company’s global growth LEESBURG, Va., March 29, 2018 -- (Healthcare Sales & Marketing Network) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of comple... Devices, Orthopaedic, Neurosurgery, Personnel K2M, Balance ACS, spinal implant, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 30, 2018 Category: Pharmaceuticals Source Type: news

Epic Sciences and Genomic Health Announce Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of the Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test in Patients with Metastatic Castration-Resistant Prostate Cancer
Medicare Draft Coverage Supports Clinical Utility of the Oncotype DX AR-V7 Nucleus Detect Test, Providing 25,000 Medicare Patients with Coverage Once LCD Is Finalized SAN DIEGO and REDWOOD CITY, Calif., March 30, 2018 -- (Healthcare Sales & Marketing Ne... Diagnostics, Oncology, Reimbursement Epic Sciences, Genomic Health, Oncotype DX AR-V7, Nucleus Detect, mCRPC (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 30, 2018 Category: Pharmaceuticals Source Type: news

TAP Blood Collection Device Receives CE Mark
MEDFORD, Mass., March 29, 2018 -- (Healthcare Sales & Marketing Network) -- Seventh Sense Biosystems (7SBio) announced today that TAP, the company's painless, one-step blood collection device, has received a CE Mark. This enables the company to begin comm... Devices, Regulatory Seventh Sense Biosystems, TAP , blood collection device (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2018 Category: Pharmaceuticals Source Type: news

Inari Medical Announces Completion of $27 Million Series C Financing
IRVINE, Calif., March 29, 2018 -- (Healthcare Sales & Marketing Network) -- Inari Medical, Inc., announced today the close of a Series C financing totaling $27.0 million. The financing was led by new investor Gilde Healthcare and was joined by all of Ina... Devices, Interventional, Venture Capital Inari Medical, FlowTriever, ClotTriever, venous thromboembolism, thrombectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2018 Category: Pharmaceuticals Source Type: news

Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor
The CardioMEMS™ Hf System Is The First and Only FDA-Approved Heart Failure Monitor Proven to Significantly Reduce Heart Failure Hospital Admissions and Improve Quality of Life New Study Will Evaluate Whether Treatment with the CardioMEMS Monitor Improve... Devices, Monitoring, Cardiology Abbott, CardioMEMS, GUIDE-HF trial, heart failure, pulmonary artery pressure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2018 Category: Pharmaceuticals Source Type: news

Crescita Announces Launch of Pliaglis in U.S.
MISSISSAUGA, ON, March 29, 2018 -- (Healthcare Sales & Marketing Network) - Crescita Therapeutics Inc. (TSX: CTX) ("Crescita" or "the Company"), a commercial dermatology company with a portfolio of non-prescription skincare products an... Biopharmaceuticals, Dermatology, Product Launch Crescita Therapeutics, Pliaglis, lidocaine, tetracaine, dermal anaesthesia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2018 Category: Pharmaceuticals Source Type: news

Abide and Celgene Enter Worldwide License Agreement for ABX-1772
Abide receives upfront payment and potential milestones and royalties SAN DIEGO, March 28, 2018 -- (Healthcare Sales & Marketing Network) -- Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeti... Biopharmaceuticals, Licensing Abide Therapeutics, serine hydrolase, Celgene (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 28, 2018 Category: Pharmaceuticals Source Type: news

Haemonetics Announces Regulatory Clearances of NexSys PCS(TM) Enhanced Software with YES(TM) Technology
Embedded Software Adds Key Capability to NexSys PCS Platform BRAINTREE, Mass., March 28, 2018 -- (Healthcare Sales & Marketing Network) -- Haemonetics Corporation (NYSE: HAE) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA... Devices, FDA, Regulatory Haemonetics, NexSys PCS, plasma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 28, 2018 Category: Pharmaceuticals Source Type: news

Mylan Introduces Symfi(TM) Triple Combo Once-Daily HIV Treatment in the U.S.
Approval complements growing portfolio of cost-saving antiretroviral medications available to patients in the U.S., including recently announced Symfi Lo™ and Cimduo™ All ARV regimens are being offered at a significant discount to the price of competing... Biopharmaceuticals, HIV/AIDS, FDA, Product Launch Mylan, Symfi, efavirenz, lamivudine, tenofovir (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 28, 2018 Category: Pharmaceuticals Source Type: news